Monitoring of surface cytotoxic drugs in the environment of hospital pharmacies in the Czech Republic
Authors:
P. Odráška 1,2; L. Gorná 1; L. Doležalová 1; M. Oravec 2; J. Kuta 2; L. Bláha 1,2
Authors place of work:
Masarykův onkologický ústav Brno
1; Masarykova univerzita Brno, Přírodovědecká fakulta, RECETOX (Výzkumné centrum pro chemii životního prostředí a ekotoxikologii)
2
Published in the journal:
Čes. slov. Farm., 2009; 58, 225-229
Category:
Original Articles
Summary
The study aimed to determine the contamination with antineoplastic (cytotoxic) drugs in 15 hospital pharmacies in the Czech Republic and to investigate the relationship between the level of contamination and the work load (number of preparations per week reported by the given pharmacy staff). For this purpose, surface contamination of the most exposed locations within the preparation and storage areas was monitored. Monitored surfaces were wiped with a nonwoven swab moistened with acetate buffer (0.02 M, pH = 4). Wipers were then extracted in the same solution and analysed for cyclophosphamide and platinum contents by high-performance liquid chromatography with mass spectrometry (HPLC-MS) and inductively coupled plasma mass spectrometry (ICP-MS), respectively. From the total of 119 collected samples, 70 samples (59%) were positive for at least one of the analytes and 43 samples (36%) were positive for both compounds studied. In general, the levels of contamination were higher in the preparation rooms than in the storage areas. Furthermore, it was shown that contamination is more frequent in those pharmacies where high numbers of preparations are routinely processed. Nevertheless, individual levels of contamination seem to be influenced also by the staff dedication and spatial organization of working areas.
Key words:
antineoplastic agents – contamination – cyclophosphamide – platinum – pharmacy
Zdroje
1. Hedmer, M., Tinnerberg, H., Axmon, A., Jonsson, B. A. G.: Int. Arch. Occup. Environ. Health, 2008; 81, 899–911.
2. Heinemann, A., Hadtstein, C.: ASUpraxis, 2009; 44, 37–39.
3. Wieringa, A., van Staveren, M. C., van der Aart-van der Beek, A., Visser, T.: Europ. J. Hosp. Pharm., 2008; 14, 94–95.
4. Kromhout, H., Hoek, F., Uitterhoeve, R., Huijbers, R., Overmars, R. F., Anzion, R., Vermeulen, R.: Ann Occup Hyg, 2000; 44, 551–560.
5. McDevitt, J. J., Lees, P. S. J., McDiarmid, M. A.: J. Occup. Environ. Med., 1993; 35, 57–60.
6. Sessink, P. J. M., Timmersmans, J. L., Anzion, R. B. M., Bos, R. P.: J. Occup. Environ. Med., 1994; 36, 79–83.
7. Sessink, P. J. M., Vandekerkhof, M. C. A., Anzion, R. B. M., Noordhoek, J., Bos, R. P.: Arch. Environ. Health, 1994; 49, 165–169.
8. DiFrancesco, R., Griggs, J. J., Donnelly, J., Di Cenzo, R.: J. Chromatogr. B, 2007; 852, 545–553.
9. Hedmer, M., Jonsson, B. A. G., Nygren, O.: J. Environ. Mon., 2004; 6, 979–984.
10. Minoia, C., Turci, R., Sottani, C., Schiavi, A., Perbellini, L., Angeleri, S., Draicchio, F., Apostoli, P.: Rapid Commun. Mass Spectrom., 1998; 12, 1485–1493.
11. Schmaus, G., Schierl, R., Funck, S.: Am. J. Health. Syst. Pharm., 2002; 59, 956–961.
12. Sessink, P. J. M., Scholtes, M. M., Anzion, R. B. M., Bos, R. P.: J. Chromatogr. Biomed. Appl., 1993; 616, 333–337.
13. Nygren, O., Gustavsson, B., Strom, L., Eriksson, R., Jarneborn, L., Friberg, A.: J. Environ. Mon., 2002; 4, 739–742.
14. Turci, R., Sottani, C., Ronchi, A., Minoia, C.: Toxicol. Lett., 2002; 134, 57–64.
15. Connor, T. H., Anderson, R. W., Sessink, P. J. M., Broadfield, L., Power, L. A.: Am. J. Health. Syst. Pharm., 1999; 56, 1427–1432.
16. Hedmer, M., Georgiadi, A., Bremberg, E. R. M., Jonsson, B. A. G.: Ann. Occup. Hyg., 2005; 49, 629–637.
17. Vandenbroucke, J., Robays, H.: J. Oncol. Pharm. Pract., 2001; 6, 146–152.
18. Sessink, P. J. M., Kroese, E. D., Vankranen, H. J., Bos, R. P.: Int. Arch. Occup. Environ. Health, 1995; 67, 317–323.
19. Čupr, P., Koptíková, J., Šantroch, J., Bartoš, T., Bednářová, Z., Mužík, J., Holoubek, I., Dušek, L.: Klin. onkol., 2007; 20, 190–196.
20. Hirst, M., Mills, D., Tse, S., Levin, L., White, D.: The Lancet, 1984; 323, 186–188.
21. Sessink, P. J. M., Boer, K. A., Scheefhals, A. P. H., Anzion, R. B. M., Bos, R. P.: Int. Arch. Occup. Environ. Health, 1992; 64, 105–112.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2009 Číslo 5-6
Najčítanejšie v tomto čísle
- Methods of preparation of microparticles in pharmaceutical technology
- Contributions to the development of advertising in pharmacy I
- Examination of selected quality parameters of the parenteral nutrition AIO – a pilot study
- Hypolipidemic effect of amaranth constituents